A cancer mystery more than 40 years old is solved thanks to epigenetics

nucleotide
Credit: CC0 Public Domain

Before the first oncogene mutations were discovered in human cancer in the early 1980s, the 1970s provided the first data suggesting alterations in the genetic material of tumors. In this context, the prestigious journal Nature published in 1975 the existence of a specific alteration in the transformed cell: an RNA responsible for carrying an amino acid to build proteins (transfer RNA) was missing a piece, the enigmatic nucleotide 'Y.'

After that outstanding observation, virtually no developments were made for forty-five years on the causes and consequences of not having the correct base in RNA.

In an article published in Proceedings of the National Academy of Sciences (PNAS) by the group of Dr. Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute, ICREA Research Professor and Professor of Genetics at the University of Barcelona has solved this mystery by observing that in the protein that generates the Y is epigenetically inactivated, causing small but highly aggressive tumors.

"Since the original discovery in 1975, there has been much biochemical work to characterize the enzymes involved in the different steps that lead to the desired nucleotide Y, a hypermodified guanine, but without connecting this characterization with its defect in tumor biology. We have built the bridge between these two worlds by demonstrating that the epigenetic silencing of the TYW2 gene is the cause of the loss of the elusive nucleotide Y," explains Dr. Esteller about the article in PNAS

Esteller adds, "Epigenetic blockade of the TYW2 gene occurs mainly in colon, stomach and uterine . And it has undesirable consequences for : the postman (RNA) that sends the signal to produce the bricks of our body (proteins) begins to accumulate errors and the cell takes on a different appearance, far from the normal epithelium, which we call mesenchymal and which it is associated with the appearance of metastasis."

"In this regard, when we study patients with colon cancer in early stages, the epigenetic defect of TYW2 and the loss of the nucleotide Y is associated with those tumors that, although small in size, already lead to decreased survival of that person. We would like to explore now how to restore the activity of the TYW2 gene and restore the necessary Y component in order to close the cycle of this story that began so brilliantly in 1975, at the dawn of modern molecular biology," concludes Esteller.


Explore further

Researchers find epigenetic loss that changes how cells obtain energy from cancer

More information: Margalida RossellĂł-Tortella et al, Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer, Proceedings of the National Academy of Sciences (2020). DOI: 10.1073/pnas.2003358117
Citation: A cancer mystery more than 40 years old is solved thanks to epigenetics (2020, August 12) retrieved 19 September 2020 from https://medicalxpress.com/news/2020-08-cancer-mystery-years-epigenetics.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
329 shares

Feedback to editors

User comments